![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, July 09, 2017 6:08:41 PM
In U. S. >140 Million suffer from chronic pain (>3 months) and actute pain (<3months), so market is immense. Share count high because company has financed a string of regulatory wins using a 'revolver technique' and fortunately have around only $10 Million in debt. You have the smarts to know it's all and only about market cap, and nothing else, once domestic sales kick in. I would also suggest you pick up a device on Amazon and try it - the 720 hour version - drug-free, side-effect from pain remediation..... $30. Simple logic, hope this helps.
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM